Drug management of visceral pain: Concepts from basic research

Pain Research and Treatment

Volumn 2012, Issue , 2012, Pages

  Davis, Mellar P ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Taussig Cancer Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868673423     PISSN: 20901542     EISSN: 20901550     Source Type: Journal    
DOI: 10.1155/2012/265605     Document Type: Review

References (274)

1. Bielefeldt K., Christianson J. A., Davis R. M., Basic and clinical aspects of visceral sensation: transmission in the CNS. Neurogastroenterology and Motility 2005 17 4 488 499 2-s2.0-23044507991 10.1111/j.1365-2982.2005. 00671.x (Pubitemid 41075990)
2. Locke G. R. III, Talley N. J., Fett S. L., Zinsmeister A. R., Melton L. J. III, Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997 112 5 1448 1456 2-s2.0-0030931230 (Pubitemid 27181367)
3. Makharia G. K., govindmakharia@aiims.ac.in Understanding and treating abdominal pain and spasms in organic gastrointestinal diseases: Inflammatory bowel disease and biliary diseases. Journal of Clinical Gastroenterology 2011 45 supplement 2 S89 S93 10.1097/MCG.0b013e31821fbd82
4. Cross R. K., Wilson K. T., Binion D. G., Narcotic use in patients with Crohn's disease. American Journal of Gastroenterology 2005 100 10 2225 2229 2-s2.0-27744443916 10.1111/j.1572-0241.2005.00256.x
5. Edwards J. T., Radford-Smith G. L., Florin T. H., Chronic narcotic use in inflammatory bowel disease patients: prevalence and clinical characteristics. Journal of Gastroenterology and Hepatology 2001 16 11 1235 1238 2-s2.0-0035700407 10.1046/j.1440-1746.2001.02468.x (Pubitemid 34088270)
6. Long M. D., Drossman D. A., Inflammatory bowel disease, irritable bowel syndrome, or what: a challenge to the functional-organic dichotomy. American Journal of Gastroenterology 2010 105 8 1796 1798 2-s2.0-77955365656 10.1038/ajg.2010.162
7. Spiller R., Garsed K., Infection, inflammation, and the irritable bowel syndrome. Digestive and Liver Disease 2009 41 12 844 849 2-s2.0-70350569462 10.1016/j.dld.2009.07.007
8. Simrén M., Axelsson J., Gillberg R., Abrahamsson H., Svedlund J., Björnsson E. S., Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. American Journal of Gastroenterology 2002 97 2 389 396 10.1016/S0002-9270(01) 04037-0 (Pubitemid 34160766)
9. Ansari R., Attari F., Razjouyan H., Etemadi A., Amjadi H., Merat S., Malekzadeh R., Ulcerative colitis and irritable bowel syndrome: relationships with quality of life. European Journal of Gastroenterology and Hepatology 2008 20 1 46 50 2-s2.0-37349033166 10.1097/MEG.0b013e3282f16a62 (Pubitemid 350307488)
10. Caraceni A., Portenoy R. K., An international survey of cancer pain characteristics and syndromes. Pain 1999 82 3 263 274 10.1016/S0304-3959(99) 00073-1 (Pubitemid 29369094)
11. Christo P. J., Mazloomdoost D., Cancer pain and analgesia. Annals of the New York Academy of Sciences 2008 1138 278 298 2-s2.0-53149139925 10.1196/annals.1414.033
12. Blackshaw L. A., Brookes S. J., Grundy D., Schemann M., Sensory transmission in the gastrointestinal tract. Neurogastroenterology and Motility 2007 19 1 1 3 2-s2.0-33846057455 10.1111/j.1365-2982.2006.00888.x
13. Grundy D., Signalling the state of the digestive tract. Autonomic Neuroscience 2006 125 1-2 76 80 2-s2.0-33646162418 10.1016/j.autneu.2006.01.009
14. Cummings D. E., davidec@u.washington.edu Frayo R. S., Marmonier C., Aubert R., Chapelot D., Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. American Journal of Physiology 2004 287 2 50-2 E297 E304 10.1152/ajpendo.00582.2003 (Pubitemid 38943896)
15. Wren A. M., Seal L. J., Cohen M. A., Brynes A. E., Frost G. S., Murphy K. G., Dhillo W. S., Ghatei M. A., Bloom S. R., Ghrelin enhances appetite and increases food intake in humans. Journal of Clinical Endocrinology and Metabolism 2001 86 12 5992 5995 2-s2.0-0035216623 10.1210/jc.86.12.5992 (Pubitemid 33152655)
16. Deutsch J. A., Young W. G., Kalogeris T. J., The stomach signals satiety. Science 1978 201 4351 165 167 2-s2.0-0018092433 (Pubitemid 8401982)
17. Moran T. H., Kinzig K. P., Gastrointestinal satiety signals. II. Cholecystokinin. American Journal of Physiology 2004 286 2 G183 G188 2-s2.0-1642539151 (Pubitemid 38134028)
18. Buyse M., Ovesjö M. L., Goïot H., Guilmeau S., Péranzi G., Moizo L., Walker F., Lewin M. J. M., Meister B., Bado A., Expression and regulation of leptin receptor proteins in afferent and efferent neurons of the vagus nerve. European Journal of Neuroscience 2001 14 1 64 72 2-s2.0-0034909166 10.1046/j.0953-816X.2001.01628.x (Pubitemid 32738475)
19. Davis M. P., The opioid bowel syndrome: a review of pathophysiology and treatment. Journal of Opioid Management 2005 1 3 153 161 2-s2.0-33947240432
20. Page A. J., O'Donnell T. A., Blackshaw L. A., Opioid modulation of ferret vagal afferent mechanosensitivity. American Journal of Physiology 2008 294 4 G963 G970 2-s2.0-42049098095 10.1152/ajpgi.00562.2007 (Pubitemid 351520069)
21. Grundy D., What activates visceral afferents? Gut 2004 53 2 ii5 ii8 2-s2.0-1242270482 (Pubitemid 38230579)
22. Robinson D. R., Gebhart G. F., Inside information: the unique features of visceral sensation. Molecular Interventions 2008 8 5 242 253 2-s2.0-56649103906 10.1124/mi.8.5.9
23. Grundy D., Schemann M., Enteric nervous system. Current Opinion in Gastroenterology 2006 22 2 102 110 2-s2.0-33745765742 10.1097/01.mog.0000208459. 46395.16 (Pubitemid 44090073)
24. Brumovsky P. R., Gebhart G. F., Visceral organ cross-sensitization-an integrated perspective. Autonomic Neuroscience 2010 153 1-2 106 115 2-s2.0-73949116431 10.1016/j.autneu.2009.07.006
25. Giamberardino M. A., Vecchiet L., Visceral pain, referred hyperalgesia and outcome: new concepts. European Journal of Anaesthesiology, Supplement 1995 12 10 61 66 2-s2.0-0029053327
26. Pezzone M. A., Liang R., Fraser M. O., A model of neural cross-talk and irritation in the pelvis: implications for the overlap of chronic pelvic pain disorders. Gastroenterology 2005 128 7 1953 1964 2-s2.0-20444458234 10.1053/j.gastro.2005.03.008 (Pubitemid 40824705)
27. Whorwell P. J., McCallum M., Creed F. H., Roberts C. T., Non-colonic features of irritable bowel syndrome. Gut 1986 27 1 37 40 2-s2.0-0022623316 (Pubitemid 16134473)
28. Sinclair D. C., Weddell G., Feindel W. H., Referred pain and associated phenomena. Brain 1948 71 2 184 211 2-s2.0-0001519097 10.1093/brain/71.2.184
29. Giamberardino M. A., Costantini R., Affaitati G., Fabrizio A., Lapenna D., Tafuri E., Mezzetti A., Viscero-visceral hyperalgesia: characterization in different clinical models. Pain 2010 151 2 307 322 2-s2.0-77957900974 10.1016/j.pain.2010.06.023
30. Ustinova E. E., Gutkin D. W., Pezzone M. A., Sensitization of pelvic nerve afferents and mast cell infiltration in the urinary bladder following chronic colonic irritation is mediated by neuropeptides. American Journal of Physiology 2007 292 1 F123 F130 2-s2.0-33846202164 10.1152/ajprenal.00162.2006 (Pubitemid 46105251)
31. Ustinova E. E., Fraser M. O., Pezzone M. A., Colonic irritation in the rat sensitizes urinary bladder afferents to mechanical and chemical stimuli: an afferent origin of pelvic organ cross-sensitization. American Journal of Physiology 2006 290 6 F1478 F1487 2-s2.0-33744791447 10.1152/ajprenal.00395.2005 (Pubitemid 43830775)
32. Cohen D. P., Ikeda S. R., Lewis D. L., Neuropeptide Y and calcitonin gene-related peptide modulate voltage- gated Ca2+ channels in mature female rat paracervical ganglion neurons. Journal of the Society for Gynecologic Investigation 1996 3 6 342 349 2-s2.0-0030297890 10.1016/S1071-5576(96)00041-X (Pubitemid 26374250)
33. Tattersall J. E., Cervero F., Lumb B. M., Viscerosomatic neurons in the lower thoracic spinal cord of the cat: excitations and inhibitions evoked by splanchnic and somatic nerve volleys and by stimulation of brain stem nuclei. Journal of Neurophysiology 1986 56 5 1411 1423 2-s2.0-0022968028 (Pubitemid 17190192)
34. Giesler G. J. Jr., Nahin R. L., Madsen A. M., Postsynaptic dorsal column pathway of the rat. I. Anatomical studies. Journal of Neurophysiology 1984 51 2 260 275 2-s2.0-0021337673 (Pubitemid 14188731)
35. Viswanathan A., Burton A. W., Rekito A., McCutcheon I. E., Commissural myelotomy in the treatment of intractable visceral pain: technique and outcomes. Stereotactic and Functional Neurosurgery 2010 88 6 374 382 2-s2.0-77957781448 10.1159/000319041
36. Becker R., Sure U., Bertalanffy H., Sindou M., Punctate midline myelotomy: a new approach in the management of visceral pain. Acta Neurochirurgica 1999 141 8 881 883 2-s2.0-0032866240 10.1007/s007010050390 (Pubitemid 29408431)
37. Willis W. D., Al-Chaer E. D., Quast M. J., Westlund K. N., A visceral pain pathway in the dorsal column of the spinal cord. Proceedings of the National Academy of Sciences of the United States of America 1999 96 14 7675 7679 2-s2.0-0033529283 10.1073/pnas.96.14.7675 (Pubitemid 29328339)
38. Ren Y., Zhang L., Lu Y., Yang H., Westlun K. N., Central lateral thalamic neurons receive noxious visceral mechanical and chemical input in rats. Journal of Neurophysiology 2009 102 1 244 258 2-s2.0-67649595159 10.1152/jn.90985.2008
39. Cao Z., Wu X., Chen S., Fan J., Zhang R., Owyang C., Li Y., Anterior cingulate cortex modulates visceral pain as measured by visceromotor responses in viscerally hypersensitive rats. Gastroenterology 2008 134 2 535 543 2-s2.0-38649114357 10.1053/j.gastro.2007.11.057 (Pubitemid 351173055)
40. Vera-Portocarrero L. P., Yie J. X., Kowal J., Ossipov M. H., King T., Porreca F., Descending facilitation from the rostral ventromedial medulla maintains visceral pain in rats with experimental pancreatitis. Gastroenterology 2006 130 7 2155 2164 2-s2.0-33744518427 10.1053/j.gastro.2006.03.025 (Pubitemid 43816956)
41. Urban M. O., Gebhart G. F., Supraspinal contributions to hyperalgesia. Proceedings of the National Academy of Sciences of the United States of America 1999 96 14 7687 7692 2-s2.0-0033529277 10.1073/pnas.96.14.7687 (Pubitemid 29328341)
42. Hwang S. J., Valtschanoff J. G., Vanilloid receptor VR1-positive afferents are distributed differently at different levels of the rat lumbar spinal cord. Neuroscience Letters 2003 349 1 41 44 2-s2.0-0142075271 10.1016/S0304-3940(03)00750-X (Pubitemid 37289266)
43. Guo A., Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neliropeptides, the P2X3 purinoceptor and IB4 binding sites. European Journal of Neuroscience 1999 11 3 946 958 2-s2.0-0032967640 (Pubitemid 29106055)
44. Valtschanoff J. G., Rustioni A., Guo A., Hwang S. J., Vanilloid receptor VR1 is both presynaptic and postsynaptic in the superficial laminae of the rat dorsal horn. Journal of Comparative Neurology 2001 436 2 225 235 2-s2.0-0035939450 10.1002/cne.1063 (Pubitemid 32622533)
45. Roberts L. A., Connor M., TRPV1 antagonists as a potential treatment for hyperalgesia. Recent Patents on CNS Drug Discovery 2006 1 1 65 76 2-s2.0-34250202592 10.2174/157488906775245309
46. Messeguer A., Planells-Cases R., Ferrer-Montiel A., Physiology and pharmacology of the vanilloid receptor. Current Neuropharmacology 2006 4 1 1 15 2-s2.0-33646024354 10.2174/157015906775202995
47. Zygmunt P. M., Petersson J., Andersson D. A., Chuang H. H., Sorgård M., Di Marzo V., Julius D., Högestätt E. D., Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999 400 6743 452 457 2-s2.0-0033614984 10.1038/22761 (Pubitemid 29361798)
48. Miranda A., Nordstrom E., Mannem A., Smith C., Banerjee B., Sengupta J. N., The role of transient receptor potential vanilloid 1 in mechanical and chemical visceral hyperalgesia following experimental colitis. Neuroscience 2007 148 4 1021 1032 2-s2.0-34548670044 10.1016/j.neuroscience.2007.05.034 (Pubitemid 47419190)
49. Kirkup A. J., Brunsden A. M., Grundy D., Receptors and transmission in the brain-gut axis: potential for novel therapies I. Receptors on visceral afferents. American Journal of Physiology 2001 280 5 G787 G794 2-s2.0-0035041595
50. Jones R. C. W. Jr., Xu L., Gebhart G. F., The mechanosensitivity of mouse colon afferent fibers and their sensitization by inflammatory mediators require transient receptor potential vanilloid 1 and acid-sensing ion channel 3. Journal of Neuroscience 2005 25 47 10981 10989 2-s2.0-28044453285 10.1523/JNEUROSCI.0703-05.2005 (Pubitemid 41692628)
51. Szallasi A., Cortright D. N., Blum C. A., Eid S. R., The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nature Reviews Drug Discovery 2007 6 5 357 372 2-s2.0-34248138496 10.1038/nrd2280 (Pubitemid 46705200)
52. Geppetti P., Trevisani M., Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function. British Journal of Pharmacology 2004 141 8 1313 1320 2-s2.0-2442608827 10.1038/sj.bjp.0705768 (Pubitemid 38638820)
53. Birder L. A., Nakamura Y., Kiss S., Nealen M. L., Barrick S., Kanai A. J., Wang E., Ruiz G., De Groat W. C., Apodaca G., Watkins S., Caterina M. J., Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nature Neuroscience 2002 5 9 856 860 2-s2.0-0036728668 10.1038/nn902 (Pubitemid 34976650)
54. Chan C. L., Facer P., Davis J. B., Smith G. D., Egerton J., Bountra C., Williams N. S., Anand P., Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. The Lancet 2003 361 9355 385 391 2-s2.0-0037309871 10.1016/S0140-6736(03)12392-6 (Pubitemid 36164972)
55. Yiangou Y., Facer P., Dyer N. H., Chan C. L. H., Knowles C., Williams N. S., Anand P., Vanilloid receptor 1 immunoreactivity in inflamed human bowel. The Lancet 2001 357 9265 1338 1339 2-s2.0-0035962308 10.1016/S0140-6736(00)04503-7 (Pubitemid 32441536)
56. Ji R. R., Samad T. A., Jin S. X., Schmoll R., Woolf C. J., p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 2002 36 1 57 68 2-s2.0-0037179755 10.1016/S0896-6273(02)00908-X
57. Premkumar L. S., Ahern G. P., Induction of vanilloid receptor channel activity by protein kinase C. Nature 2000 408 6815 985 990 2-s2.0-0034700494 10.1038/35050121 (Pubitemid 32101646)
58. Matthews P. J., Aziz Q., Facer P., Davis J. B., Thompson D. G., Anand P., Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus. European Journal of Gastroenterology and Hepatology 2004 16 9 897 902 2-s2.0-4444357719 10.1097/00042737-200409000-00014 (Pubitemid 39179660)
59. Adam B., Liebregts T., Gschossmann J. M., Krippner C., Scholl F., Ruwe M., Holtmann G., Severity of mucosal inflammation as a predictor for alterations of visceral sensory function in a rat model. Pain 2006 123 1-2 179 186 2-s2.0-33744547408 10.1016/j.pain.2006.02.029 (Pubitemid 43816772)
60. Akbar A., Yiangou Y., Facer P., Brydon W. G., Walters J. R. F., Anand P., Ghosh S., Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain. Gut 2010 59 6 767 774 2-s2.0-77953718071 10.1136/gut.2009.194449
61. Lapointe T. K., Altier C., altier@ucalgary.ca The role of TRPA1 in visceral inflammation and pain. Channels 2011 5 6 20 24
62. Cattaruzza F., Spreadbury I., Miranda-Morales M., Grady E. F., Vanner S., Bunnett N. W., Transient receptor potential ankyrin-1 has a major role in mediating visceral pain in mice. American Journal of Physiology 2010 298 1 G81 G91 2-s2.0-73549115353 10.1152/ajpgi.00221.2009
63. Waldmann R., Champigny G., Bassilana F., Heurteaux C., Lazdunski M., A proton-gated cation channel involved in acid-sensing. Nature 1997 386 6621 173 177 2-s2.0-0030946297 10.1038/386173a0 (Pubitemid 27131444)
64. Deval E., Gasull X., Noël J., Salinas M., Baron A., Diochot S., Lingueglia E., Acid-sensing ion channels (ASICs): pharmacology and implication in pain. Pharmacology and Therapeutics 2010 128 3 549 558 2-s2.0-78049273246 10.1016/j.pharmthera.2010.08.006
65. Yagi J., Wenk H. N., Naves L. A., McCleskey E. W., Sustained currents through ASIC3 ion channels at the modest pH changes that occur during myocardial ischemia. Circulation Research 2006 99 5 501 509 2-s2.0-33748362837 10.1161/01.RES.0000238388.79295.4c (Pubitemid 44337822)
66. + exchanger regulatory factor-1. Journal of Biological Chemistry 2006 281 3 1796 1807 2-s2.0-33644985209 10.1074/jbc.M509669200
67. Yiangou Y., Facer P., Smith J. A., Sangameswaran L., Eglen R., Birch R., Knowles C., Williams N., Anand P., Increased acid-sensing ion channel ASIC-3 in inflamed human intestine. European Journal of Gastroenterology and Hepatology 2001 13 8 891 896 2-s2.0-0034891491 10.1097/00042737-200108000-00003 (Pubitemid 32757004)
68. Wultsch T., Painsipp E., Shahbazian A., Mitrovic M., Edelsbrunner M., Lazdunski M., Waldmann R., Holzer P., Deletion of the acid-sensing ion channel ASIC3 prevents gastritis-induced acid hyperresponsiveness of the stomach-brainstem axis. Pain 2008 134 3 245 253 2-s2.0-37849000674 10.1016/j.pain.2007.04.025
69. Chen C. C., Zimmer A., Sun W. H., Hall J., Brownstein M. J., A role for ASIC3 in the modulation of high-intensity pain stimuli. Proceedings of the National Academy of Sciences of the United States of America 2002 99 13 8992 8997 2-s2.0-0037173123 10.1073/pnas.122245999 (Pubitemid 34693671)
70. Deval E., Noël J., Lay N., Alloui A., Diochot S., Friend V., Jodar M., Lazdunski M., Lingueglia E., ASIC3, a sensor of acidic and primary inflammatory pain. The EMBO Journal 2008 27 22 3047 3055 2-s2.0-56549096001 10.1038/emboj.2008.213
71. + channel with novel properties. Journal of Biological Chemistry 1997 272 46 28819 28822 2-s2.0-0030723559 10.1074/jbc.272.46.28819 (Pubitemid 27498156)
72. Chen X., Orser B. A., MacDonald J. F., Design and screening of ASIC inhibitors based on aromatic diamidines for combating neurological disorders. European Journal of Pharmacology 2010 648 1-3 15 23 2-s2.0-77957754480 10.1016/j.ejphar.2010.09.005
73. Voilley N., de Weille J., Mamet J., Lazdunski M., Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors. Journal of Neuroscience 2001 21 20 8026 8033 2-s2.0-0035887733 (Pubitemid 32952759)
74. Dorofeeva N. A., Barygin O. I., Staruschenko A., Bolshakov K. V., Magazanik L. G., Mechanisms of non-steroid anti-inflammatory drugs action on ASICs expressed in hippocampal interneurons. Journal of Neurochemistry 2008 106 1 429 441 2-s2.0-45249113296 10.1111/j.1471-4159.2008.05412.x (Pubitemid 351840226)
75. Page A. J., Brierley S. M., Martin C. M., Martinez-Salgado C., Wemmie J. A., Brennan T. J., Symonds E., Omari T., Lewin G. R., Welsh M. J., Blackshaw L. A., The ion channel ASIC1 contributes to visceral but not cutaneous mechanoreceptor function. Gastroenterology 2004 127 6 1739 1747 2-s2.0-9644263983 10.1053/j.gastro.2004.08.061 (Pubitemid 39575853)
76. Sutherland S. P., Benson C. J., Adelman J. P., McCleskey E. W., Acid-sensing ion channel 3 matches the acid-gated current in cardiac ischemia-sensing neurons. Proceedings of the National Academy of Sciences of the United States of America 2001 98 2 711 716 2-s2.0-0035895248 10.1073/pnas.011404498 (Pubitemid 32105108)
77. Canning B. J., Farmer D. G., Mori N., Mechanistic studies of acid-evoked coughing in anesthetized guinea pigs. American Journal of Physiology 2006 291 2 R454 R463 2-s2.0-33745818310 10.1152/ajpregu.00862.2005 (Pubitemid 44035654)
78. Catterall W. A., Cellular and molecular biology of voltage-gated sodium channels. Physiological Reviews 1992 72 supplement 4 S15 S48 2-s2.0-0026490286
79. Woolf C. J., Costigan M., Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proceedings of the National Academy of Sciences of the United States of America 1999 96 14 7723 7730 2-s2.0-0033529324 10.1073/pnas.96.14.7723 (Pubitemid 29328348)
80. Qi F. H., Zhou Y. L., Xu G. Y., guangyin.xu@gmail.com Targeting voltage-gated sodium channels for treatment for chronic visceral pain. World Journal of Gastroenterology 2011 17 19 2357 2364 10.3748/wjg.v17.i19.2357
81. Laird J. M., Souslova V., Wood J. N., Cervero F., Deficits in visceral pain and referred hyperalgesia in Nav1.8 (SNS/PN3)-null mice. Journal of Neuroscience 2002 22 19 8352 8356 2-s2.0-0036813714 (Pubitemid 35387574)
82. Hillsley K., Lin J. H., Stanisz A., Grundy D., Aerssens J., Peeters P. J., Moechars D., Coulie B., Stead R. H., Dissecting the role of sodium currents in visceral sensory neurons in a model of chronic hyperexcitability using Nav 1.8 and Nav 1.9 null mice. Journal of Physiology 2006 576 1 257 267 2-s2.0-33748888226 10.1113/jphysiol.2006.113597 (Pubitemid 44426234)
83. Cervero F., Laird J. M., Role of ion channels in mechanisms controlling gastrointestinal pain pathways. Current Opinion in Pharmacology 2003 3 6 608 612 2-s2.0-0345307677 10.1016/j.coph.2003.06.007 (Pubitemid 37451868)
84. Beyak M. J., Vanner S., Inflammation-induced hyperexcitability of nociceptive gastrointestinal DRG neurones: the role of voltage-gated ion channels. Neurogastroenterology and Motility 2005 17 2 175 186 2-s2.0-16444371904 10.1111/j.1365-2982.2004.00596.x (Pubitemid 40476677)
85. Yoshimura N., Seki S., Novakovic S. D., Tzoumaka E., Erickson V. L., Erickson K. A., Chancellor M. B., De Groat W. C., The involvement of the tetrodotoxin-resistant sodium channel Nav1.8 (PN3/SNS) in a rat model of visceral pain. Journal of Neuroscience 2001 21 21 8690 8696 2-s2.0-0035503586 (Pubitemid 33051467)
86. Gebhart G. F., Bielefeldt K., Ozaki N., Gastric hyperalgesia and changes in voltage gated sodium channel function in the rat. Gut 2002 51 1 i15 i18 2-s2.0-0036293655 (Pubitemid 34717713)
87. + currents in mouse colonic dorsal root ganglia neurons and their role in colitis-induced hyperexcitability. American Journal of Physiology 2004 287 4 G845 G855 2-s2.0-4644290610 10.1152/ajpgi.00154.2004 (Pubitemid 39280443)
88. Na in rat colonic sensory neurons. Journal of Neurophysiology 2002 88 3 1512 1522 2-s2.0-0036712354 (Pubitemid 35025404)
89. + current-reduction by celecoxib correlates with changes in PGE2 and CGRP within rat DRG neurons during acute incisional pain. Brain Research 2008 1209 C 57 64 2-s2.0-43049116097 10.1016/j.brainres.2008.02.096
90. Choi J. S., Hudmon A., Waxman S. G., Dib-Hajj S. D., Calmodulin regulates current density and frequency-dependent inhibition of sodium channel Nav1.8 in DRG neurons. Journal of Neurophysiology 2006 96 1 97 108 2-s2.0-33745737497 10.1152/jn.00854.2005 (Pubitemid 44015345)
91. Villarreal C. F., Sachs D., Funez M. I., Parada C. A., de Queiroz Cunha F., Ferreira S. H., The peripheral pro-nociceptive state induced by repetitive inflammatory stimuli involves continuous activation of protein kinase A and protein kinase C epsilon and its NaV1.8 sodium channel functional regulation in the primary sensory neuron. Biochemical Pharmacology 2009 77 5 867 877 2-s2.0-59749090393 10.1016/j.bcp.2008.11.015
92. Li P., Zhu S., Zhusy@ioz.ac.cn Molecular design of new sodium channel blockers. Biochemical and Biophysical Research Communications 2011 414 2 321 325 10.1016/j.bbrc.2011.09.052
93. Gale J. D., Houghton L. A., Alpha 2 delta (α 2 δ) ligands, gabapentin and pregabalin: what is the evidence for potential use of these ligands in irritable bowel syndrome. Frontiers in Pharmacology 2011 2 28
94. Taylor C. P., Garrido R., Immunostaining of rat brain, spinal cord, sensory neurons and skeletal muscle for calcium channel alpha2-delta (α 2- δ) type 1 protein. Neuroscience 2008 155 2 510 521 2-s2.0-49349084181 10.1016/j.neuroscience.2008.05.053
95. Cole R. L., Lechner S. M., Williams M. E., Prodanovich P., Bleicher L., Varney M. A., Gu G., Differential distribution of voltage-gated calcium channel alpha-2 delta (α 2 δ) subunit mRNA-containing cells in the rat central nervous system and the dorsal root ganglia. Journal of Comparative Neurology 2005 491 3 246 269 2-s2.0-24944549969 10.1002/cne.20693 (Pubitemid 41324594)
96. Gong H. C., Hang J., Kohler W., Li L., Su T. Z., Tissue-specific expression and gabapentin-binding properties of calcium channel α 2 δ subunit subtypes. Journal of Membrane Biology 2001 184 1 35 43 2-s2.0-0035498469 10.1007/s00232-001-0072-7 (Pubitemid 33016169)
97. Hendrich J., Van Minh A. T., Heblich F., Nieto-Rostro M., Watschinger K., Striessnig J., Wratten J., Davies A., Dolphin A. C., Pharmacological disruption of calcium channel trafficking by the α 2 δ ligand gabapentin. Proceedings of the National Academy of Sciences of the United States of America 2008 105 9 3628 3633 2-s2.0-42149144087 10.1073/pnas.0708930105 (Pubitemid 351723603)
98. v2.1 trafficking. Molecular Pharmacology 2008 74 3 904 912 2-s2.0-50449098420 10.1124/mol.108.045153
99. 3H norepinephrine release from rat neocortical slices by gabapentin and pregabalin. Journal of Pharmacology and Experimental Therapeutics 2000 295 3 1086 1093 2-s2.0-0033696481
100. Patel M. K., Gonzalez M. I., Bramwell S., Pinnock R. D., Lee K., Gabapentin inhibits excitatory synaptic transmission in the hyperalgesic spinal cord. British Journal of Pharmacology 2000 130 8 1731 1734 2-s2.0-0033849424 (Pubitemid 30655783)
101. Field M. J., Cox P. J., Stott E., Melrose H., Offord J., Su T. Z., Bramwell S., Corradini L., England S., Winks J., Kinloch R. A., Hendrich J., Dolphin A. C., Webbl T., Williams D., Identification of the α 2- δ -1 subunit of voltage-calcium calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proceedings of the National Academy of Sciences of the United States of America 2006 103 46 17537 17542 2-s2.0-33751232667 10.1073/pnas.0409066103 (Pubitemid 44789004)
102. Field M. J., Holloman E. F., McCleary S., Hughes J., Singh L., Evaluation of gabapentin and S-(+)-3-isobutylgaba in a rat model of postoperative pain. Journal of Pharmacology and Experimental Therapeutics 1997 282 3 1242 1246 2-s2.0-0030886662 (Pubitemid 27408300)
103. Field M. J., Oles R. J., Lewis A. S., McCleary S., Hughes J., Singh L., Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. British Journal of Pharmacology 1997 121 8 1513 1522 2-s2.0-0030796031 10.1038/sj.bjp.0701320 (Pubitemid 27343376)
104. Million M., Wang L., Adelson D. W., Roman F., Diop L., Taché Y., Pregabalin decreases visceral pain and prevents spinal neuronal activation in rats. Gut 2007 56 10 1482 1484 2-s2.0-34948851724 10.1136/gut.2007.129304
105. Lee K. J., kjleemd@hotmail.com Kim J. H., Cho S. W., Gabapentin reduces rectal mechanosensitivity and increases rectal compliance in patients with diarrhoea-predominant irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 2005 22 10 981 988 10.1111/j.1365-2036.2005.02685.x (Pubitemid 41634880)
106. Houghton L. A., Fell C., Whorwell P. J., Jones I., Sudworth D. P., Gale J. D., Effect of a second-generation α 2 δ ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome. Gut 2007 56 9 1218 1225 2-s2.0-34548127061 10.1136/gut.2006.110858 (Pubitemid 47300421)
107. Diop L., Raymond F., Fargeau H., Petoux F., Chovet M., Doherty A. M., Pregabalin (Cl-1008) inhibits the trinitrobenzene sulfonic acid-induced chronic colonic allodynia in the rat. Journal of Pharmacology and Experimental Therapeutics 2002 302 3 1013 1022 2-s2.0-0036707535 10.1124/jpet.302.3.1013 (Pubitemid 34920221)
108. Feng Y., Cui M., Willis W. D., Gabapentin markedly reduces acetic acid-induced visceral nociception. Anesthesiology 2003 98 3 729 733 2-s2.0-0037370351 10.1097/00000542-200303000-00023 (Pubitemid 36262602)
109. Stepanovíc-Petrovíc R. M., racabbr@eunet.yu Tomíc M. A., Vučkovíc S. M., Paranos S., Ugrešíc N. D., Prostran M. S., Milovanovíc S., Boškovíc B., The antinociceptive effects of anticonvulsants in a mouse visceral pain model. Anesthesia and Analgesia 2008 106 6 1897 1903 10.1213/ane.0b013e318172b993
110. Reihanikermani H., Ansari M., Soltani A., Meymandi M. S., Amitriptyline pharmacokinetics in experimental spinal cord injury in the rabbit. Indian Journal of Pharmaceutical Sciences 2008 70 6 782 785 2-s2.0-64349110067 10.4103/0250-474X.49122
111. Ravnefjord A., Brusberg M., Larsson H., Lindström E., Martínez V., vicente.martinez@astrazeneca.com Effects of pregabalin on visceral pain responses and colonic compliance in rats. British Journal of Pharmacology 2008 155 3 407 416 10.1038/bjp.2008.259
112. Marger F., Gelot A., Alloui A., Matricon J., Sanguesa Ferrer J. F., Barrère C., Pizzoccaro A., Muller E., Nargeot J., Snutch T. P., Eschalier A., Bourinet E., emmanuel.bourinet@igf.cnrs.fr Ardid D., T-type calcium channels contribute to colonic hypersensitivity in a rat model of irritable bowel syndrome. Proceedings of the National Academy of Sciences of the United States of America 2011 108 27 11268 11273 10.1073/pnas.1100869108
113. Jiang W., Kirkup A. J., Grundy D., d.grundy@sheffield.ac.uk Mast cells drive mesenteric afferent signalling during acute intestinal ischaemia. Journal of Physiology 2011 589 15 3867 3882 10.1113/jphysiol.2011.209478
114. Ding Y. Q., Li J. L., Lü B. Z., Wang D., Miao-Li Zhang, Li J. S., Co-localization of μ -opioid receptor-like immunoreactivity with substance P-LI, calcitonin gene-related peptide-LI and nitric oxide synthase- LI in vagal and glossopharyngeal afferent neurons of the rat. Brain Research 1998 792 1 149 153 2-s2.0-0032482144 10.1016/S0006-8993(98)00205-4 (Pubitemid 28261180)
115. Aicher S. A., Goldberg A., Sharma S., Pickel V. M., μ -opioid receptors present in vagal afferents and their dendritic targets in the medial nucleus tractus solitarius. Journal of Comparative Neurology 2000 422 2 181 190 2-s2.0-0034717937 10.1002/(SICI)1096-9861(20000626)422:2181::AID-CNE3>3.0. CO;2-G (Pubitemid 30390163)
116. Rau K. K., Caudle R. M., Cooper B. Y., Johnson R. D., Diverse immunocytochemical expression of opioid receptors in electrophysiologically defined cells of rat dorsal root ganglia. Journal of Chemical Neuroanatomy 2005 29 4 255 264 2-s2.0-20144381100 10.1016/j.jchemneu.2005.02.002 (Pubitemid 40775812)
117. Bueno L., Fioramonti J., Action of opiates on gastrointestinal function. Bailliere's Clinical Gastroenterology 1988 2 1 123 139 2-s2.0-0023892826
118. Ahlbeck K., karsten@narkos.se Opioids: a two-faced Janus. Current Medical Research and Opinion 2011 27 2 439 448 10.1185/03007995.2010.545379
119. Rimoy G. H., Wright D. M., Bhaskar N. K., Rubin P. C., The cardiovascular and central nervous system effects in the human of U-62066E. A selective opioid receptor agonist. European Journal of Clinical Pharmacology 1994 46 3 203 207 (Pubitemid 24137427)
120. Kumor K. M., Haertzen C. A., Johnson R. E., Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo. Journal of Pharmacology and Experimental Therapeutics 1986 238 3 960 968 (Pubitemid 17183699)
121. Grundy D., d.grundy@sheffield.ac.uk Booth C. E., Winchester W., Hicks G. A., Peripheral opiate action on afferent fibres supplying the rat intestine. Neurogastroenterology and Motility 2004 16 supplement 2 29 37 10.1111/j.1743-3150.2004.00557.x (Pubitemid 39468864)
122. Eastwood C., Grundy D., Opioid-receptor-mediated excitation of rat mesenteric afferent fibres supplying the rat jejunum. Neurogastroenterology and Motility 2000 12 6 517 522 2-s2.0-0034536724 10.1046/j.1365-2982.2000.00226.x (Pubitemid 32001449)
123. Gray A. C., White P. J., Coupar I. M., Characterisation of opioid receptors involved in modulating circular and longitudinal muscle contraction in the rat ileum. British Journal of Pharmacology 2005 144 5 687 694 2-s2.0-15944428255 10.1038/sj.bjp.0706107 (Pubitemid 40445617)
124. Lian B., Vera-Portocarrero L., King T., Ossipov M. H., Porreca F., Opioid-induced latent sensitization in a model of non-inflammatory viscerosomatic hypersensitivity. Brain Research C 2010 1358 64 70 2-s2.0-77957358303 10.1016/j.brainres.2010.08.032
125. Su X., Sengupta J. N., Gebhart G. F., Effects of kappa opioid receptor-selective agonists on responses of pelvic nerve afferents to noxious colorectal distension. Journal of Neurophysiology 1997 78 2 1003 1012 2-s2.0-0030857396 (Pubitemid 27353561)
126. Burton M. B., Gebhart G. F., Effects of kappa-opioid receptor agonists on responses to colorectal distension in rats with and without acute colonic inflammation. Journal of Pharmacology and Experimental Therapeutics 1998 285 2 707 715 2-s2.0-0031836946 (Pubitemid 28237452)
127. Herrero J. F., Headley P. M., The effects of sham and full spinalization on the systemic potency of μ-and κ -opioids on spinal nociceptive reflexes in rats. British Journal of Pharmacology 1991 104 1 166 170
128. Rivière P. J., Pierre.Riviere@Ferring.com Peripheral kappa-opioid agonists for visceral pain. British Journal of Pharmacology 2004 141 8 1331 1334 10.1038/sj.bjp.0705763 (Pubitemid 38638822)
129. Kivell B., Prisinzano T. E., Kappa opioids and the modulation of pain. Psychopharmacology 2010 209 2 109 119 2-s2.0-77953287151 10.1007/s00213-010- 1819-6
130. Gebhart G. F., Su X., Joshi S., Ozaki N., Sengupta J. N., Peripheral opioid modulation of visceral pain. Annals of the New York Academy of Sciences 2000 909 41 50 2-s2.0-0033913116 (Pubitemid 30462032)
131. Ackley M. A., Hurley R. W., Virnich D. E., Hammond D. L., A cellular mechanism for the antinociceptive effect of a kappa opioid receptor agonist. Pain 2001 91 3 377 388 2-s2.0-0035076328 10.1016/S0304-3959(00)00464-4 (Pubitemid 32241160)
132. Sengupta J. N., Snider A., Su X., Gebhart G. F., Effects of kappa opioids in the inflamed rat colon. Pain 1999 79 2-3 175 185 2-s2.0-0033057419 10.1016/S0304-3959(98)00175-4 (Pubitemid 29076752)
133. Simonin F., Valverde O., Smadja C., Slowe S., Kitchen L., Dierich A., Le Meur M., Roques B. P., Maldonado R., Kieffer B. L., Disruption of the κ -opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective κ -agonist U-50,488H and attenuates morphine withdrawal. The EMBO Journal 1998 17 4 886 897 2-s2.0-0032481350 10.1093/emboj/17.4.886 (Pubitemid 28077643)
134. Arendt-Nielsen L., Olesen A. E., Staahl C., Menzaghi F., Kell S., Wong G. Y., Drewes A. M., Analgesic efficacy of peripheral κ -opioid receptor agonist CR665 Compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective effect on visceral pain. Anesthesiology 2009 111 3 616 624 2-s2.0-69549122425 10.1097/ALN.0b013e3181af6356
135. Delgado-Aros S., Chial H. J., Cremonini F., Ferber I., McKinzie S., Burton D. D., Camilleri M., camilleri.michael@mayo.edu Effects of asimadoline, a κ -opioid agonist, on satiation and postprandial symptoms in health. Alimentary Pharmacology and Therapeutics 2003 18 5 507 514 10.1046/j.1365-2036. 2003.01670.x (Pubitemid 37152291)
136. Camilleri M., camilleri.michael@mayo.edu Novel pharmacology: asimadoline, a κ -opioid agonist, and visceral sensation. Neurogastroenterology and Motility 2008 20 9 971 979 10.1111/j.1365-2982.2008.01183.x
137. Szarka L. A., Camilleri M., camilleri.michael@mayo.edu Burton D., Fox J. C., McKinzie S., Stanislav T., Simonson J., Sullivan N., Zinsmeister A. R., Efficacy of on-demand asimadoline, a peripheral κ -opioid agonist, in females with irritable bowel syndrome. Clinical Gastroenterology and Hepatology 2007 5 11 1268 1275 10.1016/j.cgh.2007.07.011 (Pubitemid 350019057)
138. Delvaux M., Pharmacology and clinical experience with fedotozine. Expert Opinion on Investigational Drugs 2001 10 1 97 110 2-s2.0-0035190470 10.1517/13543784.10.1.97 (Pubitemid 32014156)
139. Bonaz B., Riviere P. J., Sinniger V., Fedotozine, a kappa-opioid agonist, prevents spinal and supra-spinal Fos expression induced by a noxious visceral stimulus in the rat. Neurogastroenterology and Motility 2000 12 2 135 147 (Pubitemid 30182074)
140. Jones K. L., kjones@medicine.adelaide.edu.au Wishart J. M., Berry M. K., Abitbol J.-L., Horowitz M., Effects of fedotozine on gastric emptying and upper gastrointestinal symptoms in diabetic gastroparesis. Alimentary Pharmacology and Therapeutics 2000 14 7 937 943 10.1046/j.1365-2036.2000.00790.x (Pubitemid 30446906)
141. Eisenach J. C., Carpenter R., Curry R., Analgesia from a peripherally active κ -opioid receptor agonist in patients with chronic pancreatitis. Pain 2003 101 1-2 89 95 2-s2.0-0037223119 10.1016/S0304-3959(02)00259-2 (Pubitemid 36044656)
142. Vanderah T. W., vanderah@u.arizona.edu Largent-Milnes T., Lai J., Porreca F., Houghten R. A., Menzaghi F., Wisniewski K., Stalewski J., Sueiras-Diaz J., Galyean R., Schteingart C., Junien J. -L., Trojnar J., Rivière P. J.-M., Novel d-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral κ -opioid receptors,. European Journal of Pharmacology 2008 583 1 62 72 10.1016/j.ejphar.2008.01.011
143. Al-Khrasani M., Lackó E., Riba P., Király K., Sobor M., Timár J., Mousa S., Schäfer M., Fürst S., furzsu@pharma.sote.hu The central versus peripheral antinociceptive effects of μ -opioid receptor agonists in the new model of rat visceral pain. Brain Research Bulletin 2012 87 2-3 238 243 10.1016/j.brainresbull.2011.10.018
144. Greenwood-Van Meerveld B., Gardner C. J., Little P. J., Hicks G. A., Dehaven-Hudkins D. L., Dehaven-Hudkins DL. Preclinical studies of opioids and opioid antagonists on gastrointestinal function. Neurogastroenterology & Motility 2004 16 supplement 2 46 53 10.1111/j.1743-3150.2004.00555.x (Pubitemid 39468866)
145. Sandner-Kiesling A., Eisenach J. C., Pharmacology of opioid inhibition to noxious uterine cervical distension. Anesthesiology 2002 97 4 966 971 2-s2.0-0036792254
146. Larsson M., Arvidsson S., Ekman C., Bayati A., A model for chronic quantitative studies of colorectal sensitivity using balloon distension in conscious mice-effects of opioid receptor agonists. Neurogastroenterology and Motility 2003 15 4 371 381 2-s2.0-0038037164 10.1046/j.1365-2982.2003.00418.x (Pubitemid 36876252)
147. Sengupta J. N., Su X., Gebhart G. F., κ but not μ or δ opioids attenuate responses to distention of afferent fibers innervating the rat colon. Gastroenterology 1996 111 4 968 980 (Pubitemid 26327599)
148. Larsson M. H., marie.h.larsson@astrazeneca.com Bayati A., Lindström E., Larsson H., Involvement of κ -opioid receptors in visceral nociception in mice. Neurogastroenterology and Motility 2008 20 10 1157 1164 10.1111/j.1365-2982.2008.01161.x
149. Briggs S. L., Rech R. H., Antinociceptive interactions of micro- and kappa-opioid agonists in the colorectal distension assay in rats. Pharmacology Biochemistry and Behavior 2009 92 2 343 350
150. Staahl C., Christrup L. L., Andersen S. D., Arendt-Nielsen L., Drewes A. M., A comparative study of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model. Pain 2006 123 1-2 28 36 2-s2.0-33744511725 10.1016/j.pain.2006.02.006 (Pubitemid 43816754)
151. B receptors on vagal afferent pathways: peripheral and central inhibition. American Journal of Physiology Gastrointestinal and Liver Physiology 2001 280 4 G658 G668
152. BR expressed on vagal afferent neurones inhibit gastric mechanosensitivity in ferret proximal stomac. American Journal of Physiology Gastrointestinal and Liver Physiology 2001 281 6 G1494 G1501
153. B receptor activation inhibits N- and P/Q-type calcium channels in cultured lamprey sensory neurons. Brain Research 1999 847 2 175 185 2-s2.0-0345534813 10.1016/S0006-8993(99)02002- 8
154. 2+ current in sympathetic neurons. Journal of Neuroscience 2000 20 8 2867 2874 2-s2.0-0034655872 (Pubitemid 30220312)
155. B receptors couple to potassium and calcium channels on identified lateral perforant pathway projection neurons. Journal of Neurophysiology 2000 83 2 1073 1078 2-s2.0-0033967735 (Pubitemid 30091314)
156. B receptor agonist on distension-sensitive pelvic nerve afferent fibers innervating rat colon. American Journal of Physiology Gastrointestinal and Liver Physiology 2002 283 6 G1343 G1351 (Pubitemid 35351122)
157. Brusberg M., Ravnefjord A., Martinsson R., Larsson H., Martinez V., Lindström E., The GABAB receptor agonist, baclofen, and the positive allosteric modulator, CGP7930, inhibit visceral pain-related responses to colorectal distension in rats. Neuropharmacology 2009 56 362 367 2-s2.0-58549112362 10.1016/j.neuropharm.2008.09.006
158. Hara K., Saito Y., ysaito@shimane-med.ac.jp Kirihara Y., Yamada Y., Sakura S., Kosaka Y., The interaction of antinociceptive effects of morphine and GABA receptor agonists within the rat spinal cord. Anesthesia and Analgesia 1999 89 2 422 427 10.1097/00000539-199908000-00032 (Pubitemid 29367728)
159. Lindström E., Erik.Lindstrom@medivir.se Brusberg M., Ravnefjord A., Kakol-Palm D., Påhlman I., Novéén A., Larsson H., Martinez V., vicente.martinez@uab.es Oral baclofen reduces visceral pain-related pseudo-affective responses to colorectal distension in rats: relation between plasma exposure and efficacy. Scandinavian Journal of Gastroenterology 2011 46 6 652 662 10.3109/00365521.2011.560677
160. Birder L. A., de Groat W. C., Contribution of C-fiber afferent nerves and autonomic pathways in the urinary bladder to spinal c-fos expression induced by bladder irritation. Somatosensory and Motor Research 1998 15 1 5 12 2-s2.0-0031943890 10.1080/08990229870916 (Pubitemid 28172168)
161. Lu Y., Westlund K. N., Effects of baclofen on colon inflammation-induced Fos, CGRP and SP expression in spinal cord and brainstem. Brain Research 2001 889 1-2 118 130 2-s2.0-0035910321 10.1016/S0006-8993(00)03124-3 (Pubitemid 32146274)
162. A receptor activation. Neuroscience 2001 103 3 725 737 2-s2.0-0035925692 10.1016/S0306-4522(00)00571-6 (Pubitemid 32239338)
163. Wang Y., Wu J., Lin Q., Nauta H. J., Yue Y., Fang L., Effects of general anesthetics on visceral pain transmission in the spinal cord. Molecular Pain 2008 4, article 50 2-s2.0-56649091454 10.1186/1744-8069-4-50
164. Dong X. P., Xu T. L., The actions of propofol on γ -aminobutyric acid-A and glycine receptors in acutely dissociated spinal dorsal horn neurons of the rat. Anesthesia and Analgesia 2002 95 4 907 914
165. Herman R. M., D'Luzansky S. C., Ippolito R., Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study. Clinical Journal of Pain 1992 8 4 338 345 2-s2.0-0027103035 (Pubitemid 23039034)
166. Slonimski M., Abram S. E., Zuniga R. E., Intrathecal baclofen in pain management. Regional Anesthesia and Pain Medicine 2004 29 3 269 276 2-s2.0-2542448231 10.1016/j.rapm.2004.01.005 (Pubitemid 38685824)
167. Harmer J. P., Larson B. S., Pain relief from baclofen analgesia in a neuropathic pain patient who failed opioid and pharmacotherapy: case report. Journal of Pain and Palliative Care Pharmacotherapy 2002 16 3 61 64 2-s2.0-0036446676 (Pubitemid 35415830)
168. Zuniga R. E., Perera S., Abram S. E., Intrathecal baclofen: a useful agent in the treatment of well-established complex regional pain syndrome. Regional Anesthesia and Pain Medicine 2002 27 1 90 93 2-s2.0-0036146635 10.1053/rapm.2002.29244 (Pubitemid 34093285)
169. Zuniga R. E., Schlicht C. R., Abram S. E., Intrathecal baclofen is analgesic in patients with chronic pain. Anesthesiology 2000 92 3 876 880 2-s2.0-0034014122 (Pubitemid 30130195)
170. Mayer E. A., Gebhart G. F., Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994 107 1 271 293 2-s2.0-0028338434 (Pubitemid 24195371)
171. Michaelis E. K., Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Progress in Neurobiology 1998 54 4 369 415 2-s2.0-0032473367 10.1016/S0301-0082(97)00055-5 (Pubitemid 28085741)
172. Randic M., Jiang M. C., Rusin K. I., Cerne R., Kolaj M., Interactions between excitatory amino acids and tachykinins and long-term changes of synaptic responses in the rat spinal dorsal horn. Regulatory Peptides 1993 46 1-2 418 420 2-s2.0-0027255510 (Pubitemid 23208382)
173. McRoberts J. A., Coutinho S. V., Marvizón J. C., Grady E. F., Tognetto M., Sengupta J. N., Ennes H. S., Chaban V. V., Amadesi S., Creminon C., Lanthorn T., Geppetti P., Bunnett N. W., Mayer E. A., Role of peripheral N-methyl-D-aspartate (NMDA) receptors in visceral nociception in rats. Gastroenterology 2001 120 7 1737 1748 2-s2.0-0034995837 (Pubitemid 32523492)
174. Liu H., Mantyh P. W., Basbaum A. I., NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature 1997 386 6626 721 724 2-s2.0-0030943255 (Pubitemid 27193493)
175. Wang H., Pickel V. M., Presence of NMDA-type glutamate receptors in cingulate corticostriatal terminals and their postsynaptic targets. Synapse 2000 35 4 300 310 2-s2.0-0033973083 10.1002/(SICI)1098-2396(20000315)35:4300::AID- SYN8>3.0.CO;2-C (Pubitemid 30090559)
176. Wang H., Stradtman G. G. III, Wang X. J., Gao W. J., A specialized NMDA receptor function in layer 5 recurrent microcircuitry of the adult rat prefrontal cortex. Proceedings of the National Academy of Sciences of the United States of America 2008 105 43 16791 16796 2-s2.0-55949099989 10.1073/pnas.0804318105
177. Wang H., Gracy K. N., Pickel V. M., μ -Opioid and NMDA-type glutamate receptors are often colocalized in spiny neurons within patches of the caudate-putamen nucleus. Journal of Comparative Neurology 1999 412 1 132 146 2-s2.0-0033552067 10.1002/(SICI)1096-9861(19990913)412:1132::AID-CNE10>3.0. CO;2-B (Pubitemid 29380330)
178. 3H]CNQX in human motor cortex, brainstem and spinal cord. Brain Research 1993 630 1-2 75 81 2-s2.0-0027386154 10.1016/0006-8993(93)90644-3 (Pubitemid 23342828)
179. Olivar T., Laird J. M. A., Differential effects of N -methyl-D-receptor blockade on nociceptive somatic and visceral reflexes. Pain 1999 79 1 67 73 2-s2.0-0032896940 10.1016/S0304-3959(98)00152-3 (Pubitemid 29012437)
180. Kolhekar R., Gebhart G. F., Modulation of spinal visceral nociceptive transmission by NMDA receptor activation in the rat. Journal of Neurophysiology 1996 75 6 2344 2353 2-s2.0-0030008855 (Pubitemid 26200629)
181. Ji T., Traub R. J., Spinal NMDA receptors contribute to neuronal processing of acute noxious and nonnoxious colorectal stimulation in the rat. Journal of Neurophysiology 2001 86 4 1783 1791 2-s2.0-0034786920 (Pubitemid 32953227)
182. Anand P., Aziz Q., Willert R., van Oudenhove L., lukas.vanoudenhove@med. kuleuven.be Peripheral and central mechanisms of visceral sensitization in man. Neurogastroenterology and Motility 2007 19 supplement 1 29 46 10.1111/j.1365-2982.2006.00873.x (Pubitemid 46058981)
183. 3 is increased in human inflammatory bowel disease. Neurogastroenterology and Motility 2001 13 4 365 369 2-s2.0-0034796360 10.1046/j.1365-2982.2001.00276.x (Pubitemid 32953673)
184. Bueno L., Fioramonti J., Garcia-Villar R., Pathobiology of visceral pain: molecular mechanisms and therapeutic implications. III. Visceral afferent pathways: a source of new therapeutic targets for abdominal pain. American Journal of Physiology 2000 278 5 G670 G676 (Pubitemid 30366418)
185. Gold M. S., Gebhart G. F., Nociceptor sensitization in pain pathogenesis. Nature Medicine 2010 16 11 1248 1257 2-s2.0-78149359626 10.1038/nm.2235
186. 3 receptor contributions to colon mechanosensitivity and hypersensitivity in the mouse. Gastroenterology 2009 137 6 2096 2104 2-s2.0-70649099205 10.1053/j.gastro.2009.06.048
187. 7 receptor-dependent intestinal afferent hypersensitivity in a mouse model of postinfectious irritable bowel syndrome. Journal of Immunology 2011 187 3 1467 1474 10.4049/jimmunol.1100423
188. Booth C. E., Kirkup A. J., Hicks G. A., Humphrey P. P., Grundy D., Somatostatin sst2 receptor-mediated inhibition of mesenteric afferent nerves of the jejunum in the anesthetized rat. Gastroenterology 2001 121 2 358 369 2-s2.0-0034909235 (Pubitemid 32729383)
189. Schwetz I., Naliboff B., Munakata J., Lembo T., Chang L., Matin K., Ohning G., Mayer E. A., emayer@ucla.edu Anti-hyperalgesic effect of octreotide in patients with irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 2004 19 1 123 131 10.1111/j.1365-2036.2004.01774.x (Pubitemid 38125645)
190. Klooker T. K., Kuiken S. D., Lei A., Boeckxstaens G. E., g.e.boeckxstaens@amc.uva.nl Effect of long-term treatment with octreotide on rectal sensitivity in patients with non-constipated irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 2007 26 4 605 615 10.1111/j.1365-2036. 2007.03398.x (Pubitemid 47174283)
191. O'Donnell L. J., Watson A. J., Cameron D., Farthing M. J.G., Effect of octreotide on mouth-to-caecum transit time in healthy subjects and in the irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 1990 4 2 177 182 (Pubitemid 20300407)
192. Rothenberg M., Pai R., Stuart K., Successful use of octreotide to treat ménétrier's disease: a rare cause of abdominal pain, weight loss, edema, and hypoalbuminemia. Digestive Diseases and Sciences 2009 54 7 1403 1407 2-s2.0-67349134275 10.1007/s10620-009-0754-z
193. De Conno F., Saita L., Ripamonti C., Ventafridda V., Subcutaneous octreotide in the treatment of pain in advanced cancer patients. Journal of Pain and Symptom Management 1994 9 1 34 38 2-s2.0-0027972467 10.1016/0885-3924(94) 90144-9 (Pubitemid 24061823)
194. Befon S., Mystakidou K., Lyra M., Tubanakis N., Vlahos L., Continuous subcutaneous octreotide in gastrointestinal cancer patients: pain control and β -endorphin levels. Anticancer Research C 2000 20 5 4039 4046 2-s2.0-0034529381 (Pubitemid 32002319)
195. Ducrotte P., philippe.ducrotte@chu-rouen.fr Maillot C., Leroi A. M., Lalaude O., Colin R., Denis P., Octreotide in refractory functional epigastric pain with nutritional impairment-an open study. Alimentary Pharmacology and Therapeutics 1999 13 7 969 975 10.1046/j.1365-2036.1999.00541.x (Pubitemid 29312784)
196. Malfertheiner P., Mayer D., Büchler M., Domínguez-Muñoz J. E., Schiefer B., Ditschuneit H., Treatment of pain in chronic pancreatitis by inhibition of pancreatic secretion with octreotide. Gut 1995 36 3 450 454
197. Maubach K. A., Grundy D., The role of prostaglandins in the bradykinin-induced activation of serosal afferents of the rat jejunum in vitro. Journal of Physiology 1999 515, part 1 277 285 2-s2.0-0033557706 (Pubitemid 29092640)
198. Rang H. P., Bevan S., Dray A., Chemical activation of nociceptive peripheral neurones. British Medical Bulletin 1991 47 3 534 548 2-s2.0-0025824227
199. Mueller M. H., Gong Q., Kelber O., Kasparek M. S., Sibaev A., Mansmann U., Yuce B., Li Y. Y., Storr M., Kreis M. E., A novel herbal preparation desensitizes mesenteric afferents to bradykinin in the rat small intestine. Neurogastroenterology and Motility 2009 21 4 467 476 2-s2.0-62449105966 10.1111/j.1365-2982.2008.01232.x
200. Müller M. H., Liu C. Y., Glatzle J., Weiser D., Kelber O., Enck P., Grundy D., Kreis M. E., martin.kreis@med.uni-muenchen.de STW 5 (Iberogast) reduces afferent sensitivity in the rat small intestine. Phytomedicine 2006 13 supplement 1 100 106 10.1016/j.phymed.2006.03.014 (Pubitemid 44809864)
201. Liu C. Y., Müller M. H., Glatzle J., Weiser D., Kelber O., Enck P., Grundy D., Kreis M. E., martin.kreis@med.uni-muenchen.de The herbal preparation STW 5 (Iberogast) desensitizes intestinal afferents in the rat small intestine. Neurogastroenterology and Motility 2004 16 6 759 764 10.1111/j.1365-2982.2004. 00576.x (Pubitemid 40022783)
202. Melzer J., joerg.melzer@usz.ch Rösch W., Reichling J., Brignoli R., Saller R., Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast). Alimentary Pharmacology and Therapeutics 2004 20 11-12 1279 1287 10.1111/j.1365-2036.2004.02275.x (Pubitemid 40040074)
203. Sibaev A., Yuece B., Kelber O., Weiser D., Schirra J., Göke B., Allescher H. D., Storr M., STW 5 (Iberogast) and its individual herbal components modulate intestinal electrophysiology of mice. Phytomedicine 2006 13 supplement 5 80 89 2-s2.0-33751346891 10.1016/j.phymed.2006.03.015 (Pubitemid 44809865)
204. Ammon H. P., Kelber O., Okpanyi S. N., Spasmolytic and tonic effect of Iberogast (STW 5) in intestinal smooth muscle. Phytomedicine 2006 13 1 67 74 2-s2.0-33751307694 10.1016/j.phymed.2004.06.022
205. Bullock B. P., Habener J. F., Phosphorylation of the cAMP response element binding protein CREB by cAMP-dependent protein kinase A and glycogen synthase kinase-3 alters DNA- binding affinity, conformation, and increases net charge. Biochemistry 1998 37 11 3795 3809 2-s2.0-0032539989 10.1021/bi970982t (Pubitemid 28162935)
206. Crump F. T., Dillman K. S., Craig A. M., cAMP-dependent protein kinase mediates activity-regulated synaptic targeting of NMDA receptors. Journal of Neuroscience 2001 21 14 5079 5088 2-s2.0-0035879068 (Pubitemid 32622933)
207. Hughes A. S., Averill S., King V. R., Molander C., Shortland P. J., Neurochemical characterization of neuronal populations expressing protein kinase C gamma isoform in the spinal cord and gracile nucleus of the rat. Neuroscience 2008 153 2 507 517 2-s2.0-42749090329 10.1016/j.neuroscience.2008.01.082
208. Zhang Y., Gong K., Zhou W., Shao G., Li S., Lin Q., Li J., gc123321@126.com Involvement of subtypes γ and ε of protein kinase C in colon pain induced by formalin injection. NeuroSignals 2011 19 3 142 150 10.1159/000328311
209. Galan A., Cervero F., Laird J. M., Extracellular signaling-regulated kinase-1 and -2 (ERK 1/2) mediate referred hyperalgesia in a murine model of visceral pain. Molecular Brain Research 2003 116 1-2 126 134 2-s2.0-0043021910 10.1016/S0169-328X(03)00284-5 (Pubitemid 36993703)
210. Ji R. R., Baba H., Brenner G. J., Woolf C. J., Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nature Neuroscience 1999 2 12 1114 1119 2-s2.0-0033490464 10.1038/16040 (Pubitemid 30126370)
211. Karim F., Wang C. C., Gereau R. W., Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice. Journal of Neuroscience 2001 21 11 3771 3779 2-s2.0-0035371317 (Pubitemid 32466469)
212. Lai H. H., laih@wudosis.wustl.edu Qiu C. S., Crock L. W., Morales M. E., Ness T. J., Gereau IV R. W., Activation of spinal extracellular signal-regulated kinases (ERK) 1/2 is associated with the development of visceral hyperalgesia of the bladder. Pain 2011 152 9 2117 2124 10.1016/j.pain.2011.05.017
213. Lichtenstein G. R., grl@uphs.upenn.edu Feagan B. G., Cohen R. D., Salzberg B. A., Diamond R. H., Chen D. M., Pritchard M. L., Sandborn W. J., Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clinical Gastroenterology and Hepatology 2006 4 5 621 630 10.1016/j.cgh.2006.03.002
214. Bonner G. F., Exacerbation of inflammatory bowel disease associated with use of celecoxib. American Journal of Gastroenterology 2001 96 4 1306 1308 2-s2.0-0035053685 10.1016/S0002-9270(01)02293-6 (Pubitemid 32319189)
215. Reinisch W., walter.reinisch@akh-wien.ac.at Miehsler W., Dejaco C., Harrer M., Waldhoer T., Lichtenberger C., Vogelsang H., An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia. Alimentary Pharmacology and Therapeutics 2003 17 11 1371 1380 10.1046/j.1365-2036.2003.01596.x (Pubitemid 36774144)
216. Ripamonti C., Mercadante S., Groff L., Zecca E., De Conno F., Casuccio A., Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. Journal of Pain and Symptom Management 2000 19 1 23 34 2-s2.0-0033980027 10.1016/S0885-3924(99)00147-5 (Pubitemid 30067620)
217. Mercadante S., Ripamonti C., Casuccio A., Zecca E., Groff L., Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction. Supportive Care in Cancer 2000 8 3 188 191 2-s2.0-0034125626 (Pubitemid 30183034)
218. Guzman F., Braun C., Lim R. K., Potter G. D., Rodgers D. W., Narcotic and non-narcotic analgesics which block visceral pain evoked by intra-arterial injection of bradykinin and other algesic agents. Arch Int Pharmacodyn Ther 1964 149 571 588
219. Meymandi M. S., Sepehri G., Gabapentin action and interaction on the antinociceptive effect of morphine on visceral pain in mice. European Journal of Anaesthesiology 2008 25 2 129 134 2-s2.0-38049011309 10.1017/S0265021507001226
220. Gaensler E. A., Quantitative determination of the visceral pain threshold in man; characteristics of visceral pain, effect of inflammation and analgesics on the threshold, and relationship of analgesia to visceral spasm. The Journal of Clinical Investigation 1951 30 4 406 420 2-s2.0-38649113708
221. Olesen A. E., Staahl C., Arendt-Nielsen L., Drewes A. M., Different effects of morphine and oxycodone in experimentally evoked hyperalgesia: a human translational study. British Journal of Clinical Pharmacology 2010 70 2 189 200 2-s2.0-77954505370 10.1111/j.1365-2125.2010.03700.x
222. Nelson K., Walsh D., Sheehan F., Cancer and chemotherapy-related upper gastrointestinal symptoms: the role of abnormal gastric motor function and its evaluation in cancer patients. Supportive Care in Cancer 2002 10 6 455 461 2-s2.0-0036940618 10.1007/s00520-002-0340-9 (Pubitemid 36056269)
223. Iwata H., Tsuchiya S., Nakamura T., Yano S., Morphine leads to contraction of the ileal circular muscle via inhibition of the nitrergic pathway in mice. European Journal of Pharmacology 2007 574 1 66 70 2-s2.0-34848866879 10.1016/j.ejphar.2007.06.029 (Pubitemid 47503159)
224. Iwata H., Tsuchiya S., Ueno K., Nakamura T., Yano S., Morphine-6-glucuronide induces contraction of the ileal circular muscle more potently than morphine in mice. European Journal of Pharmacology 2008 600 1-3 130 132 2-s2.0-55949093717 10.1016/j.ejphar.2008.10.009
225. Corleto V. D., Severi C., Romano G., Tattoli I., Weber H. C., Stridsberg M., Rindi G., Campanini N., Tomassoni F., Pagotto U., Coy D. H., Jensen R. T., Delle Fave G., Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells. Neurogastroenterology and Motility 2006 18 3 217 225 2-s2.0-33645061014 10.1111/j.1365-2982.2005.00752.x
226. Gu Z.-F., Corleto V. D., Mantey S. A., Coy D. H., Maton P. N., Jensen R. T., Somatostatin receptor subtype 3 mediates the inhibitory action of somatostatin on gastric smooth muscle cells. American Journal of Physiology 1995 268 5, part 1 G739 G748
227. Erdek M. A., merdek@jhmi.edu Halpert D. E., Fernández M. G., Cohen S. P., Assessment of celiac plexus block and neurolysis outcomes and technique in the management of refractory visceral cancer pain. Pain Medicine 2010 11 1 92 100 10.1111/j.1526-4637.2009.00756.x
228. Nair R. T., vanSonnenberg E., Shankar S., Morrison P. R., Gill R. R., Tuncali K., Silverman S. G., Visceral and soft-tissue tumors: radiofrequency and alcohol ablation for pain relief- initial experience. Radiology 2008 248 3 1067 1076 2-s2.0-51549117761 10.1148/radiol.2483061883
229. Kapural L., Deer T., Yakovlev A., Bensitel T., Hayek S., Pyles S., Khan Y., Kapural A., Cooper D., Stearns L., Zovkic P., Technical aspects of spinal cord stimulation for managing chronic visceral abdominal pain: the results from the national survey. Pain Medicine 2010 11 5 685 691 2-s2.0-77953719237 10.1111/j.1526-4637.2010.00806.x
230. Caraceni A., Portenoy R. K., Pain management in patients with pancreatic carcinoma. Cancer 1996 78 3, supplement 639 653 2-s2.0-0029944148 (Pubitemid 26251524)
231. Sarkar S., Aziz Q., Woolf C. J., Hobson A. R., Thompson D. G., Contribution of central sensitisation to the development of non-cardiac chest pain. The Lancet 2000 356 9236 1154 1159 2-s2.0-0034734670
232. Neumann S., Doubell T. P., Leslie T., Woolf C. J., Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature 1996 384 6607 360 364 2-s2.0-0029954092 10.1038/384360a0 (Pubitemid 26408518)
233. Ji R. R., Woolf C. J., Neuronal plasticity and signal transduction in nociceptive neurons: Implications for the initiation and maintenance of pathological pain. Neurobiology of Disease 2001 8 1 1 10 2-s2.0-0035116529 10.1006/nbdi.2000.0360 (Pubitemid 32171813)
234. Graham G. G., Scott K. F., Mechanism of action of paracetamol. American Journal of Therapeutics 2005 12 1 46 55 2-s2.0-17144408419 10.1097/00045391- 200501000-00008 (Pubitemid 40516046)
235. Graham G. G., Scott K. F., Mechanisms of action of paracetamol and related analgesics. Inflammopharmacology 2003 11 4 401 413 2-s2.0-0842284230 10.1163/156856003322699573 (Pubitemid 38175948)
236. Pelissier T., Alloui A., Paeile C., Eschalier A., Evidence of a central antinociceptive effect of paracetamol involving spinal 5HT3 receptors. NeuroReport 1995 6 11 1546 1548 2-s2.0-0029124268
237. Pelissier T., Alloui A., Caussade F., Dubray C., Cloarec A., Lavarenne J., Eschalier A., Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3 receptors: in vivo and in vitro evidence. Journal of Pharmacology and Experimental Therapeutics 1996 278 1 8 14 2-s2.0-0030426275 (Pubitemid 27167073)
238. Qiu H. X., Liu J., Kong H., Liu Y., Mei X. G., Isobolographic analysis of the antinociceptive interactions between ketoprofen and paracetamol. European Journal of Pharmacology 2007 557 2-3 141 146 2-s2.0-33846608239 10.1016/j.ejphar.2006.11.017 (Pubitemid 46186289)
239. Miranda H. F., Puig M. M., Prieto J. C., Pinardi G., Synergism between paracetamol and nonsteroidal anti-inflammatory drugs in experimental acute pain. Pain 2006 121 1-2 22 28 2-s2.0-32944464344 10.1016/j.pain.2005.11.012 (Pubitemid 43261628)
240. Miranda H. F., Prieto J. C., Puig M. M., Pinardi G., gpinardi@med.uchile. cl Isobolographic analysis of multimodal analgesia in an animal model of visceral acute pain. Pharmacology Biochemistry and Behavior 2008 88 4 481 486 10.1016/j.pbb.2007.10.005 (Pubitemid 350266792)
241. Ong C. K., cliffong@pacific.net.sg Seymour R. A., Lirk P., Merry A. F., Combining paracetamol (acetaminophen) with nonsteroidal antiinflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain. Anesthesia and Analgesia 2010 110 4 1170 1179 10.1213/ANE.0b013e3181cf9281
242. Mercadante S., Casuccio A., Agnello A., Pumo S., Kargar J., Garofalo S., Analgesic effects of nonsteroidal anti-inflammatory drugs in cancer pain due to somatic or visceral mechanisms. Journal of Pain and Symptom Management 1999 17 5 351 356 2-s2.0-0032964955 10.1016/S0885-3924(98)00141-9 (Pubitemid 29239526)
243. McNicol E., Strassels S. A., Goudas L., Lau J., Carr D. B., NSAIDS or paracetamol, alone or combined with opioids, for cancer pain. Cochrane Database of Systematic Reviews 2005 1 CD005180 2-s2.0-18944385512
244. Olsen J. C., McGrath N. A., Schwarz D. G., Cutcliffe B. J., Stern J. L., A double-blind randomized clinical trial evaluating the analgesic efficacy of ketorolac versus butorphanol for patients with suspected biliary colic in the emergency department. Academic Emergency Medicine 2008 15 8 718 722 2-s2.0-56849114791 10.1111/j.1553-2712.2008.00178.x
245. Morgan G., Beneficial effects of NSAIDs in the gastrointestinal tract. European Journal of Gastroenterology and Hepatology 1999 11 4 393 400 (Pubitemid 29199839)
246. Meyers D., Feldstein D. A., Initial treatment of biliary colic: are NSAIDs better than opiates? Wisconsin Medical Journal 2005 104 4 9 63 2-s2.0-24944571101
247. NSAIDS for renal and biliary colic: intramuscular diclofenac. Drug and Therapeutics Bulletin 1987 25 22 85 86
248. Kulkarni S. K., Patil C. S., Jain N. K., Singh A., Modulatory effect of diclofenac on antispasmodic effect of pitofenone in cholinergic spasm. Indian Journal of Experimental Biology 2004 42 6 567 569 2-s2.0-2942594148 (Pubitemid 38730090)
249. Akriviadis E. A., Hatzigavriel M., Kapnias D., Kirimlidis J., Markantas A., Garyfallos A., Treatment of biliary colic with diclofenac: a randomized, double-blind, placebo-controlled study. Gastroenterology 1997 113 1 225 231 2-s2.0-0030927315 10.1016/S0016-5085(97)70099-4 (Pubitemid 27281778)
250. Al-Waili N., Saloom K. Y., The analgesic effect of intravenous tenoxicam in symptomatic treatment of biliary colic: a comparison with hyoscine N-butylbromide. European Journal of Medical Research 1998 3 10 475 479 2-s2.0-0032517225
251. Mora Durban M. J., Extramiana Cameno J., Arrizabalaga Moreno M., Flubiprofen vs dipyrone combined with hyoscine: the analgesic efficacy in renal colic. Archivos Españoles de Urología 1995 48 9 867 873
252. Holdgate A., Pollock T., Nonsteroidal anti-inflammatory drugs (NSAIDs) versus opioids for acute renal colic. Cochrane Database of Systematic Reviews 2004 18 2 CD004137 2-s2.0-2942748253
253. Hatoum O. A., Miura H., Binion D. G., The vascular contribution in the pathogenesis of inflammatory bowel disease. American Journal of Physiology 2003 285 5 H1791 H1796 2-s2.0-0142200971 (Pubitemid 37305919)
254. Hatoum O. A., Binion D. G., Otterson M. F., Gutterman D. D., Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilation. Gastroenterology 2003 125 1 58 69 2-s2.0-0038449206 10.1016/S0016-5085(03)00699-1 (Pubitemid 36799107)
255. Jensen M. K., Thomsen A. B., Hojsted J., 10-year follow-up of chronic non-malignant pain patients: opioid use, health related quality of life and health care utilization. European Journal of Pain 2006 10 5 423 433 2-s2.0-33646856385 10.1016/j.ejpain.2005.06.001 (Pubitemid 43786449)
256. Burns J. W., Bruehl S., Anger management style, opioid analgesic use, and chronic pain severity: a test of the opioid-deficit hypothesis. Journal of Behavioral Medicine 2005 28 6 555 563 2-s2.0-33344455667 10.1007/s10865-005- 9020-9 (Pubitemid 43289625)
257. Tuteja A. K., Biskupiak J., Stoddard G. J., Lipman A. G., Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain. Neurogastroenterology and Motility 2010 22 4 424 e96 2-s2.0-77949290974
258. Choung R. S., Locke G. R. III, Zinsmeister A. R., Schleck C. D., Talley N. J., Opioid bowel dysfunction and narcotic bowel syndrome: a population-based study. American Journal of Gastroenterology 2009 104 5 1199 1204 2-s2.0-66949173732 10.1038/ajg.2009.71
259. Okada-Ogawa A., Porreca F., Meng I. D., Sustained morphine-induced sensitization and loss of diffuse noxious inhibitory controls in dura-sensitive medullary dorsal horn neurons. Journal of Neuroscience 2009 29 50 15828 15835 2-s2.0-72449180419 10.1523/JNEUROSCI.3623-09.2009
260. Bannister K., kirsty.bannister@ucl.ac.uk Sikandar S., Bauer C. S., Dolphin A. C., Porreca F., Dickenson A. H., Pregabalin suppresses spinal neuronal hyperexcitability and visceral hypersensitivity in the absence of peripheral pathophysiology. Anesthesiology 2011 115 1 144 152 10.1097/ALN.0b013e31821f6545
261. Célèrier E., Laulin J. P., Corcuff J. B., Le Moal M., Simonnet G., Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process. Journal of Neuroscience 2001 21 11 4074 4080 2-s2.0-0035370642 (Pubitemid 32466499)
262. Koppert W., koppert@kfa.imed.uni-erlangen.de Schmelz M., The impact of opioid-induced hyperalgesia for postoperative pain. Best Practice and Research 2007 21 1 65 83 10.1016/j.bpa.2006.12.004 (Pubitemid 46478026)
263. Fine P. G., Opioid insights: opioid-induced hyperalgesia and opioid rotation. Journal of Pain and Palliative Care Pharmacotherapy 2004 18 3 75 79 2-s2.0-6344272091 10.1300/J354v18n0308 (Pubitemid 39392187)
264. Raehal K. M., Schmid C. L., Groer C. E., Bohn L. M., lbohn@scripps.edu Functional selectivity at the μ -opioid receptor: implications for understanding opioid analgesia and tolerance. Pharmacological Reviews 2011 63 4 1001 1019 10.1124/pr.111.004598
265. Angst M. S., Clark J. D., Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 2006 104 3 570 587 2-s2.0-33645509700 10.1097/00000542-200603000-00025
266. Liguori S., Gottardi M., Micheletto G., Bruno L., Pharmacological approach to chronic visceral pain. Focus on oxycodone controlled release: an open multicentric study. European Review for Medical and Pharmacological Sciences 2010 14 3 185 190 2-s2.0-77951643453
267. Mercadante S., Tirelli W., David F., Arcara C., Fulfaro F., Casuccio A., Gebbia V., Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study. Clinical Journal of Pain 2010 26 9 794 797 2-s2.0-77958490955 10.1097/AJP.0b013e3181ecd895
268. Johnston S., steven.johnston@ecu.edu.au Wilkes G. J., Thompson J. A., Ziman M., Brightwell R., Inhaled methoxyflurane and intranasal fentanyl for prehospital management of visceral pain in an Australian ambulance service. Emergency Medicine Journal 2011 28 1 57 63 10.1136/emj.2009.078717
269. Chen S. R., Pan H. L., Loss of TRPV1-expressing sensory neurons reduces spinal μ opioid receptors but paradoxically potentiates opioid analgesia. Journal of Neurophysiology 2006 95 5 3086 3096 2-s2.0-33646201710 10.1152/jn.01343.2005
270. Fernández-Dueñas V., vfernandez@ub.edu Poveda R., Fernández A., Sánchez S., Planas E., Ciruela F., Fentanyl-trazodone-paracetamol triple drug combination: multimodal analgesia in a mouse model of visceral pain. Pharmacology Biochemistry and Behavior 2011 98 3 331 336 10.1016/j.pbb.2011.01.023
271. Maves T. J., Pechman P. S., Meller S. T., Gebhart G. F., Ketorolac potentiates morphine antinociception during visceral nociception in the rat. Anesthesiology 1994 80 5 1094 1101 2-s2.0-0028287363 (Pubitemid 24150890)
272. Romero A., Miranda H. F., Puig M. M., Analysis of the opioid-opioid combinations according to the nociceptive stimulus in mice. Pharmacological Research 2010 61 6 511 518 2-s2.0-77952885754 10.1016/j.phrs.2010.02.011
273. Ulger F., Bozkurt A., bozkurtayhan@hotmail.com Bilge S. S., Ilkaya F., Dilek A., Bostanci M. Ö., Çiftciolu E., Güldouş F., The antinociceptive effects of intravenous dexmedetomidine in colorectal distension-induced visceral pain in rats: the role of opioid receptors. Anesthesia and Analgesia 2009 109 2 616 622 10.1213/ane.0b013e3181a9fae2
274. Micó J. A., Ardid D., Berrocoso E., Eschalier A., Antidepressants and pain. Trends in Pharmacological Sciences 2006 27 7 348 354 2-s2.0-33745506283 10.1016/j.tips.2006.05.004 (Pubitemid 43963184)